<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.957" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">483</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M265.530 320.300 L273.270 320.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 331.300 L82.360 331.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,69.364,71.866,76.366,80.866,83.863,86.113,87.688,91.684,94.186,96.688,100.684,103.186,107.182,109.432,111.007,114.004,117.001,120.997,125.497,129.997,133.993,138.493,142.489,146.989,149.239,150.814,155.89,158.14,159.715,164.215,166.465,170.965,175.465,177.715,179.29,185.788,189.784,192.781,196.777,199.027,200.602,204.598,209.098,213.094,215.596,220.096,224.596,228.592,233.092,235.342,237.592,239.167,244.171,248.671,252.172,255.673,258.175,262.675,265.177,269.173,271.423,272.998,276.994,279.991,284.491,288.991,291.493,293.995,297.991" svgx:width="0.78,0.28,0.5,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.55,0.56,0.5,0.39,0.39,0.28,0.5,0.28,0.44,0.25,0.55,0.44,0.33,0.5,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">minor allele frequency &lt; 0.01 were excluded. Possible cryptic </text>
   <text y="88.101" x="62.362,65.359,69.355,71.857,75.853,78.355,82.351,86.851,91.351,95.347,98.848,102.349,104.599,105.517,110.017,113.014,115.264,116.182,120.682,125.182,129.682,134.182,136.684,140.68,143.182,145.684,150.184,154.684,156.934,157.852,161.353,163.855,166.852,170.848,173.35,175.852,178.849,181.351,185.347,189.343,191.845,194.347,198.847,203.347,205.597,206.515,210.511,217.513,222.013,226.513,231.013,233.263,234.181,236.683,241.183,245.179,247.429,248.347,251.848,256.348,260.848,263.35,267.346,271.342,273.844,277.345,279.595,280.513,287.011,291.007,294.004,298.0" svgx:width="0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.5,0.44,0.39,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.78,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relatedness or population stratification among the subjects were </text>
   <text y="99.099" x="62.362,66.358,70.858,74.854,77.356,81.856,85.852,88.354,92.35,96.85,99.1,103.6,107.101,109.603,114.103,118.603,120.853,125.857,131.356,134.353,140.851,147.349,149.599,153.595,158.095,162.595,164.845,170.344,173.341,179.839,185.338,191.836,196.84,202.339,208.342,213.841,219.178,221.428,224.425,228.421,231.922,236.422,240.418,244.414,246.916,249.418,253.918,257.914,260.416,264.331" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.56,0.61,0.33,0.72,0.72,0.25,0.44,0.5,0.5,0.25,0.61,0.33,0.72,0.61,0.72,0.56,0.61,0.67,0.72,0.61,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evaluated using PLINK and EIGENSTRAT respectively.</text>
   <text y="110.097" x="74.359,80.857,83.359,86.86,90.856,95.356,99.856,103.852,106.849,111.349,113.788,117.289,119.791,123.787,128.287,132.283,134.722,138.718,143.218,147.214,149.716,154.216,157.717,160.219,163.72,166.159,172.657,176.653,180.154,182.593,187.093,191.089,194.086,197.083,201.583,204.58,211.582,215.578,220.078,222.517,227.017,231.517,233.956,237.952,240.391,242.893,247.393,249.895,253.891,256.393,258.832,263.332,266.329,268.768,273.268,277.768,282.268,284.518,289.018,293.518,298.018" svgx:width="0.72,0.28,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.39,0.28,0.44,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Discovery stage analysis was performed on a total of 284,577 </text>
   <text y="121.095" x="62.362,67.366,73.864,78.868,82.369,85.123,89.623,94.123,96.625,100.621,103.123,107.623,111.619,116.119,118.873,121.87,124.867,129.367,136.369,139.123,143.623,148.123,152.623,154.882,161.38,165.88,169.381,171.883,174.88,178.876,181.378,183.88,187.876,192.376,195.13,198.127,203.131,209.629,214.21,216.964,219.466,222.463,226.459,230.455,232.957,236.953,241.453,244.207,248.707,252.703,255.205,257.707,261.703,266.203,268.705,272.206,274.96,277.957,283.96,289.036,293.536,298.036" svgx:width="0.56,0.72,0.56,0.39,0.25,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.5,0.25,0.72,0.5,0.39,0.28,0.33,0.44,0.28,0.28,0.44,0.5,0.25,0.33,0.56,0.72,0.51,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.67,0.56,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">SNPs obtained from 127 Australian IFNβ treated patients (R=51 </text>
   <text y="132.093" x="62.362,69.364,71.614,72.901,79.399,85.402,90.478,94.978,99.478,102.475,104.725,106.975,108.262,113.266,116.263,118.765,123.265,126.262,128.764,131.266,133.768,137.764,141.76,144.262,146.764,151.264,155.764,158.014,159.301,163.801,166.798,169.048,170.335,175.339,181.837,186.841,190.342,192.592,193.879,196.876,201.376,204.373,206.623,207.91,210.412,214.912,218.908,221.158,222.445,226.945,230.941,233.443,235.945,240.445,244.441,246.943,249.445,253.945,258.445,260.695,261.982,265.483,267.985,271.981,276.481,280.477,282.727,284.014,290.512,294.508,298.009" svgx:width="0.78,0.25,0.55,0.72,0.67,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.56,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.72,0.56,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&amp; NR=76). Prioritization of SNPs for the validation stage was </text>
   <text y="143.091" x="62.362,66.862,70.858,74.359,78.355,82.855,85.483,89.983,94.483,97.12,101.791,104.419,108.919,112.915,115.417,119.917,123.913,127.414,130.042,134.542,138.538,143.038,147.034,150.031,154.027,156.529,160.525,165.025,167.653,172.153,176.653,179.29,183.286,187.786,194.788,199.288,201.79,206.29,210.286,212.788,215.29,219.79,224.29,226.918,231.418,234.415,237.052,241.048,243.883,246.88,249.382,253.378,255.88,259.876,264.376,268.372,272.872,275.5,278.497,282.997,287.497,291.997,295.498,298.0" svgx:width="0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.56,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.33,0.5,0.5,0.5,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">based on P values generated by combination of efficiency robust </text>
   <text y="154.089" x="62.362,65.863,68.365,72.361,74.863,77.365,80.866,83.368,85.87,89.866,93.862,96.364,98.821,101.323,105.319,108.82,111.322,113.824,118.324,122.824,125.281,128.782,131.284,134.281,138.277,140.779,144.775,149.275,151.777,155.773,159.274,161.731,165.232,169.732,173.728,178.228,180.685,184.681,188.182,190.639,198.64,205.138,211.636,216.136,218.593,222.589,227.089,231.589,234.046,238.546,241.543,246.043,250.543,255.043,258.04,260.542,263.044,267.544,272.044,276.04,278.542,280.999,285.499,289.999,294.499,298.0" svgx:width="0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.89,0.72,0.72,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">statistical testing strategies such as MAX4 and proportional odds </text>
   <text y="165.087" x="62.362,69.364,73.864,78.364,82.36,84.862,87.112,89.542,94.213,96.643,101.143,105.139,107.641,112.141,116.137,119.638,122.068,128.566,132.562,135.559,139.555,141.985,145.981,148.483,151.984,156.484,158.914,162.91,167.41,170.407,173.404,177.4,181.396,183.898,187.894,192.394,194.824,197.326,201.826,204.256,208.252,212.248,216.244,220.744,225.244,229.744,232.246,234.676,237.673,242.173,245.17,247.6,252.1,256.096,259.093,261.595,265.591,270.091,272.593,276.589,279.019,283.519,287.515,291.016,295.012" svgx:width="0.78,0.5,0.5,0.44,0.28,0.25,0.25,0.56,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.39,0.5,0.25,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.44,0.5,0.5,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">model. P values were also corrected to account for variable base-</text>
   <text y="176.085" x="62.362,64.864,67.366,71.866,75.862,78.112,82.108,86.608,91.108,95.104,98.101,100.603,104.599,107.101,111.097,114.598" svgx:width="0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line covariates.</text>
   <text y="187.083" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="187.083" x="97.453,101.953,106.453,110.953,113.203,115.048,118.549,121.051,125.047,127.549,130.051,133.552,136.054,138.556,142.552,146.548,149.05,151.552,156.052,158.302,160.147,163.648,166.15,170.65,175.15,177.652,180.649,183.151,187.147,191.143,195.643,198.145,200.395,202.24,207.244,213.742,218.746,222.247,224.497,226.342,229.339,232.336,236.836,243.838,246.088,247.933,250.435,254.935,258.931,261.181,263.026,267.526,270.028,273.529,277.525,282.025,286.525,290.521,293.518,298.018" svgx:width="0.5,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.56,0.72,0.56,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">339 statistically significant SNPs from the discovery </text>
   <text y="198.081" x="62.362,65.863,68.365,72.361,76.861,80.857,83.764,90.262,94.258,97.255,101.251,104.158,107.659,111.655,114.157,118.153,122.149,124.651,128.647,133.147,136.054,139.051,143.551,146.548,149.455,152.452,156.448,160.948,163.45,165.952,169.948,173.944,176.446,178.948,183.448,187.948,190.855,193.357,197.857,200.773,203.275,207.775,211.771,214.678,219.178,223.174,225.676,228.178,232.678,236.674,239.176,241.678,246.178,250.678,253.594,257.59,262.09,266.59,271.09,274.087,276.589,279.496,283.492,287.992,294.994" svgx:width="0.39,0.28,0.44,0.5,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.33,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stage were selected for replication in the validation cohort com-</text>
   <text y="209.079" x="62.362,66.862,69.859,72.361,75.862,78.364,82.864,87.364,89.254,93.754,96.751,98.641,103.141,107.641,112.141,114.031,117.028,122.032,128.53,133.111,135.001,137.503,140.5,144.496,148.492,150.994,154.99,159.49,161.38,169.381,174.385,176.275,180.775,184.771,187.273,189.775,193.771,198.271,200.773,204.274,206.164,209.161,215.164,220.24,224.74,229.24,233.74,235.63,242.632,244.522,251.02,257.023,262.099,266.599,271.099,275.599,278.596,280.486,283.483,286.48,290.98,297.982" svgx:width="0.5,0.33,0.28,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.33,0.56,0.72,0.51,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.67,0.56,0.5,0.5,0.5,0.25,0.78,0.25,0.72,0.67,0.56,0.5,0.5,0.5,0.33,0.25,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prising of 479 IFNβ treated MS patients (R=273 &amp; NR=206) from </text>
   <text y="220.077" x="62.362,68.86,73.36,76.861,79.363,82.36,86.356,88.858,91.36,95.356,97.606,99.856,101.026,104.023,106.525,110.521,113.023,117.523,119.773,120.943,127.945,130.195,131.365,136.369,140.869,144.865,147.367,151.867,154.117,156.367,157.042,163.54,168.04,172.036,174.538,179.038,182.539,185.041,188.542,190.792,191.962,196.462,199.459,201.709,202.879,205.381,209.881,213.877,216.127,217.297,221.293,225.793,232.795,237.295,239.797,243.793,246.295,250.291,252.541,253.711,258.211,262.207,264.709,268.705,270.955,272.125,278.623,281.125,283.627,286.129,288.379,289.549,294.049,298.045" svgx:width="0.72,0.5,0.39,0.28,0.33,0.44,0.28,0.28,0.44,0.25,0.25,0.55,0.33,0.28,0.44,0.28,0.5,0.25,0.55,0.78,0.25,0.55,0.56,0.5,0.44,0.28,0.5,0.25,0.25,0.55,0.72,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.28,0.25,0.55,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Australia, Italy &amp; Spain. Analysis of the complete data will be </text>
   <text y="231.075" x="62.362,66.862,69.859,73.855,77.356,81.352,85.852,88.354,92.35,96.85,99.1,103.096,105.598,107.848,110.35,114.85,118.846,121.096,125.092,129.592,134.092,137.089,141.085,144.082,148.078,152.578,156.574,160.57" svgx:width="0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">presented at the conference.</text>
   <text y="242.073" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="242.073" x="114.121,120.124,124.624,129.124,133.12,135.622,140.122,143.623,146.125,150.625,155.125,158.626,160.876,167.374,169.876,172.378,174.88,177.13,181.63,185.626,187.876,192.376,195.373,199.369,202.87,206.866,211.366,213.868,217.864,222.364,224.614,228.61,231.112,233.362,235.864,240.364,244.36,246.61,250.606,255.106,259.606,262.603,266.599,269.596,273.592,278.092,282.088,286.084" svgx:width="0.67,0.5,0.5,0.44,0.28,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Conclusions will be presented at the conference.</text>
   <text y="275.076" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P952</text>
   <text y="286.074" x="62.362,67.861,70.363,75.367,79.867,84.367,86.869,89.371,96.868,101.368,106.372,108.622,113.626,117.622,122.122,129.619,134.119,137.116,141.112,144.613,146.863,150.859,154.855,159.355,164.359,166.861,171.361,174.358,178.858,182.854,187.354,189.604,194.608,199.612,203.608,208.612,213.112,216.109,220.609,225.613,229.609,231.859,236.359,241.363,246.367" svgx:width="0.61,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.56,0.44,0.5,0.83,0.5,0.33,0.44,0.39,0.25,0.44,0.44,0.5,0.56,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.56,0.56,0.44,0.56,0.5,0.33,0.5,0.56,0.44,0.25,0.5,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fingolimod promotes regulatory phenotype and </text>
   <text y="297.072" x="62.362,65.359,70.363,75.367,79.363,82.36,84.862,89.362,94.366,96.616,99.118,104.122,106.372,112.375,115.372,119.368,123.364,125.866,128.368,131.869,134.119,138.619,141.616,143.866,151.363,156.367,158.869,161.866,164.368,169.372,171.874,175.87,178.12,181.621,185.617,188.119,192.115,196.111,200.611,204.112,206.614,210.115,212.365,217.369,221.869,224.866,227.368,231.364,236.368,239.365" svgx:width="0.33,0.56,0.56,0.44,0.33,0.28,0.5,0.56,0.25,0.28,0.56,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.33,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">function in B-cells of multiple sclerosis patients</text>
   <text y="308.07" x="62.362,68.365,70.615,77.113,80.11,84.61,87.112,91.108,95.608" svgx:width="0.67,0.25,0.72,0.33,0.5,0.28,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B Grützke</text>
   <text y="305.583" x="99.604" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="308.103" x="102.529,104.779,107.029,112.033,114.283,120.781,125.281,129.277,133.777" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Hucke</text>
   <text y="305.583" x="137.772" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="308.103" x="140.697,142.947,145.197,151.2,157.203,159.453,165.951,168.948,173.448,176.949" svgx:width="0.25,0.25,0.67,0.67,0.25,0.72,0.33,0.5,0.39,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CC Gross</text>
   <text y="305.583" x="180.45" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="308.103" x="183.375,185.625,187.875,195.876,198.126,204.624,208.62,211.617,216.117,218.619" svgx:width="0.25,0.25,0.89,0.25,0.72,0.44,0.33,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Herold</text>
   <text y="305.583" x="223.118" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="308.103" x="226.043,228.293,230.543,236.546,238.796,247.292,249.794,252.296,256.796,260.792,267.794,271.79,276.29" svgx:width="0.25,0.25,0.67,0.25,0.94,0.28,0.28,0.5,0.44,0.78,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Wildemann</text>
   <text y="305.583" x="280.79" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="308.103" x="283.715,285.965" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="319.101" x="62.36,68.858,71.108,76.112,80.612,84.113,88.109,92.609,95.111,97.613,101.609,104.606,109.61,113.606,116.108,119.105,123.101" svgx:width="0.72,0.25,0.56,0.5,0.39,0.44,0.5,0.28,0.28,0.44,0.33,0.56,0.44,0.28,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Posevitz-Fejfar</text>
   <text y="316.583" x="126.099" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="319.103" x="129.024,131.274,133.524,139.527,141.777,148.275,150.777,154.773,158.274,162.27,164.772,168.768" svgx:width="0.25,0.25,0.67,0.25,0.72,0.28,0.44,0.39,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Kieseier</text>
   <text y="316.583" x="171.764" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="319.103" x="174.689,176.939,179.189,184.688,186.938,193.436,197.432,201.932,208.934,212.93" svgx:width="0.25,0.25,0.61,0.25,0.72,0.44,0.5,0.78,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Dehmel</text>
   <text y="316.583" x="215.432" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="319.103" x="218.357,220.607,222.857,229.355,231.605,240.101,242.603,246.599,251.099,255.599" svgx:width="0.25,0.25,0.72,0.25,0.94,0.28,0.44,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H Wiendl</text>
   <text y="316.583" x="258.101" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="319.103" x="261.026,263.276,265.526,271.025" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L </text>
   <text y="330.101" x="62.36,68.858,71.36,75.86,78.362" svgx:width="0.72,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Klotz</text>
   <text y="327.583" x="82.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="338.581" x="62.365" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="341.103" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,111.529,116.029,119.53,124.03,126.532,129.034,133.534,136.036,138.286,145.783,150.283,154.783,158.284,160.786,164.782,168.283,170.533,172.783,179.281,183.277,187.777,192.277,195.778,198.28,204.778,208.774,213.274,215.776,218.026,222.526,225.028,227.278,233.281,237.277,241.777,245.278,249.778,252.28,256.78,261.28,265.276,267.526" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.83,0.5,0.5,0.39,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital Münster, Department of Neurology, </text>
   <text y="352.101" x="62.362,69.859,74.359,78.859,82.36,84.862,88.858,92.359,94.609,96.859,103.357,107.353,110.854,117.352,121.852,126.352,130.348,132.598" svgx:width="0.83,0.5,0.5,0.39,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Münster, Germany, </text>
   <text y="349.583" x="134.847" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="352.103" x="137.772,144.27,148.77,151.272,155.268,159.264,162.765,166.266,168.768,171.27,175.266,177.516,182.016,184.518,186.768,193.266,197.262,199.764,204.264,208.26,210.762,215.262,219.258,222.759,227.259,229.509,231.759,238.257,242.253,246.753,251.253,254.754,257.256,263.754,267.75,272.25,274.752,277.002,281.502,284.004" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.72,0.44,0.28,0.5,0.44,0.28,0.5,0.44,0.39,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Heidelberg, Department of </text>
   <text y="363.101" x="62.361,68.364,72.36,76.86,80.361,84.861,87.363,91.863,96.363,100.359,102.609,104.859,111.357,115.353,117.855,122.355,126.351,128.853,133.353,137.349,140.85,145.35,147.6,149.85,156.348,160.344,163.845,170.343,174.843,179.343,183.339,185.589" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.44,0.28,0.5,0.44,0.28,0.5,0.44,0.39,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurology, Heidelberg, Germany, </text>
   <text y="360.583" x="187.839" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="363.103" x="190.764,197.262,201.762,204.264,208.26,212.256,215.757,219.258,221.76,224.262,228.258,230.508,235.008,237.51,239.76,246.258,250.758,254.259,257.76,261.756,264.258,268.758,273.258,276.759,279.261,281.511" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.72,0.5,0.39,0.39,0.44,0.28,0.5,0.5,0.39,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Düsseldorf, </text>
   <text y="374.101" x="62.361,68.859,72.855,77.355,81.855,85.356,87.858,94.356,98.352,102.852,105.354,107.604,112.104,114.606,116.856,122.859,126.855,131.355,134.856,139.356,141.858,146.358,150.858,154.854,157.104,159.354,165.852,170.352,173.853,177.354,181.35,183.852,188.352,192.852,196.353,198.855,201.105,203.355,209.853,213.849,217.35,223.848,228.348,232.848" svgx:width="0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.39,0.39,0.44,0.28,0.5,0.5,0.39,0.28,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Department of Neurology, Düsseldorf, Germany</text>
   <text y="401.101" x="62.361,68.364,72.864,76.86,81.864,86.364,90.198,94.698,99.702,104.706,109.71,112.707" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="401.101" x="116.469,121.473,123.975,128.475,132.975,137.475,139.977,142.479,149.481,153.981,158.481,160.731,162.243,164.745,168.246,170.496,172.008,176.004,178.254,179.766,182.763,186.759,190.755,194.751,199.251,201.753,204.255,208.755,211.005,212.517,216.513,221.013,225.513,228.51,233.01,237.51,241.506,246.006,248.256,249.768,252.27,255.267,259.263,263.259,265.761,272.763,276.759,281.259,283.761,286.011,287.523,290.52,295.02,298.017" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod is a recently approved treatment for </text>
   <text y="412.099" x="62.361,69.363,73.863,76.365,78.867,81.369,85.869,88.371,92.367,94.617,95.886,99.387,103.383,105.885,109.881,112.878,117.378,120.879,123.381,126.882,129.132,131.382,132.651,136.647,138.897,140.166,144.162,148.662,151.659,156.159,160.659,163.161,167.157,169.407,170.676,173.178,177.678,180.675,183.177,187.173,194.175,201.177,205.173,207.675,212.175,215.172,219.672,221.922,223.191,227.691,230.193,233.694,237.69,241.686,245.187,249.183,251.433,252.702,257.202,260.199,262.449,263.718,266.22,270.72,274.716,276.966,278.235,284.238,290.736,295.74,297.99" svgx:width="0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multiple sclerosis, a chronic inflammatory disease of the CNS, </text>
   <text y="423.097" x="62.361,66.357,68.859,75.861,79.857,84.357,86.445,90.441,92.943,95.031,98.028,102.024,106.524,111.024,115.02,117.522,122.022,126.522,128.61,131.112,135.612,139.608,141.696,146.196,150.696,157.698,162.198,166.194,169.191,171.279,175.779,178.776,180.864,185.364,189.864,192.366,196.362,200.862,203.364,205.866,209.862,212.364,214.866,219.366,221.454,225.45,229.95,232.452,236.952,239.949,243.945,247.941,251.937,254.439,256.941,261.441,265.437,267.525,270.027,274.527,281.529,286.029,290.529,295.029" svgx:width="0.44,0.28,0.78,0.44,0.5,0.25,0.44,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.28,0.5,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">aimed at reducing the number of potentially autoreactive lympho-</text>
   <text y="434.095" x="62.361,66.357,70.857,73.359,77.355,80.856,83.484,85.986,90.486,93.114,95.616,100.116,104.112,106.74,111.24,115.236,118.233,120.735,125.235,129.735,133.731,136.728,140.724,143.226,145.854,150.354,152.856,157.356,161.856,166.356,168.984,172.98,177.48,181.98,184.608,187.11,191.61,195.606,198.603,202.599,207.099,211.599,214.227,216.729,219.231,226.233,228.735,231.237,233.739,238.239,242.739,245.367,247.869,252.369,256.365,258.867,261.864,264.492,266.994,273.996,280.998,283.5,288.0,290.997,294.993" svgx:width="0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.28,0.28,0.78,0.28,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.28,0.78,0.78,0.28,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytes in the peripheral blood and thereby limiting their immigra-</text>
   <text y="445.093" x="62.361,64.863,67.365,71.865,76.365,78.615,79.47,81.972,86.472,88.974,93.474,95.724,96.579,99.081,103.581,107.577,109.827,110.682,116.685,123.183,128.187,130.437,132.687,133.38,138.879,143.379,147.375,149.625,150.48,152.982,157.482,160.479,162.981,167.481,171.477,175.977,179.973,183.969,186.219,187.074,191.574,194.571,196.821,197.676,202.68,205.182,209.682,214.182,218.682,221.184,223.686,230.688,235.188,239.688,241.938,242.793,245.295,248.292,252.288,256.284,258.786,265.788,269.784,274.284,276.786,279.036,279.891,284.391,288.891,291.141,291.996,297.999" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.56,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion into the CNS. The influence of Fingolimod treatment on B </text>
   <text y="456.091" x="62.361,66.357,70.353,72.855,75.357,77.652,81.153,85.653,90.153,93.654,97.65,100.152,103.653,105.948,110.448,113.445,115.74,122.742,127.242,129.744,132.246,134.748,139.248,141.75,145.746,148.041,151.542,155.538,158.04,162.036,165.033,169.533,173.034,175.536,179.037,181.332,185.832,189.828,192.33,194.832,198.828,203.328,205.83,209.331,211.626,215.622,220.122,224.622,226.917,229.419,231.921,235.422,237.717,242.217,246.717,249.219,253.215,257.715,260.217,262.719,266.715,269.217,271.512,275.508,278.01,280.512,285.012,287.514,291.51,295.506,298.008" svgx:width="0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cell subsets of multiple sclerosis patients and its potential clinical </text>
   <text y="467.089" x="62.361,65.358,69.354,71.856,75.852,80.352,84.348,88.848,92.844,96.84,99.09,103.59,107.586,112.086,116.082,118.332,122.832,127.332,129.834,132.084,136.584,140.58,144.576,149.076,151.326,155.322,159.822,163.818,166.32,170.82,174.816,177.318,181.314,185.814,188.064,190.314,193.815,198.315,200.565,203.562,207.558,210.06" svgx:width="0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.25,0.39,0.5,0.25,0.33,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relevance have not been evaluated, so far.</text>
   <text y="478.087" x="62.361,69.363,74.367,77.364,81.36,85.356,88.353,90.855,95.355,99.351,102.852,105.849" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="478.087" x="108.729,114.228,118.728,122.724,125.604,129.6,132.102,139.104,141.984,146.484,149.481,152.361,156.861,161.361,164.358,167.238,170.739,173.241,177.741,182.241,186.741,189.621,196.119,200.115,203.616,206.496,208.998,213.498,216.378,220.374,224.874,228.87,231.372,235.872,239.868,242.37,246.366,249.246,251.748,256.248,260.244,263.124,265.626,272.628,277.128,281.124,285.12,287.622,290.502,295.002,297.999" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.5,0.5,0.33,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of our study was to evaluate the impact of </text>
   <text y="489.085" x="62.361,67.365,69.867,74.367,78.867,83.367,85.869,88.371,95.373,99.873,104.373,106.668,109.17,112.167,116.163,120.159,122.661,129.663,133.659,138.159,140.661,142.956,147.456,151.956,154.251,160.254,162.549,166.545,170.541,173.043,175.545,177.84,181.341,185.841,190.341,193.842,197.838,200.34,202.635,206.631,211.131,218.133,222.633,227.133,230.634,233.136,235.638,238.14,242.64,247.14,249.435,251.937,256.437,258.732,261.234,265.734,269.73,272.025,276.525,280.521,283.518,286.02,290.52,295.02" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod treatment on B cell subset composition in the periph-</text>
   <text y="500.083" x="62.361,66.357,69.354,73.854,75.96,79.956,84.456,88.956,91.062,93.564,98.064,102.06,104.166,108.162,112.158,115.155,119.151,123.651,126.648,131.148,134.649,139.149,141.651,146.151,150.147,152.649,154.755,157.752,160.254,164.754,167.256,171.756,173.862,176.859,182.862,187.866,192.87,195.867,197.973,201.969,206.469,210.969,213.075,219.078,221.184,225.18,229.176,231.678,234.18,236.286,239.283,243.783,248.283,252.279,254.781,257.283,261.783,266.283,269.784,271.89,275.391,279.891,283.887,288.387,290.493,294.489,297.99" svgx:width="0.44,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.33,0.44,0.5,0.33,0.5,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25,0.33,0.67,0.56,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ery and the cerebrospinal fluid (CSF) and B cell functions such as </text>
   <text y="511.081" x="62.361,66.357,70.857,73.359,77.859,82.359,84.861,89.361,93.357,95.607,100.107,103.104,107.604,112.104,116.604,120.6,123.102,125.604,130.104,134.604,136.854,140.85,145.35,149.85,152.1,159.102,161.604,166.104,169.101,173.097,175.599,180.099,183.096,187.596,189.846,193.842,197.838,202.338,206.334,210.33,212.832,215.334,219.249" svgx:width="0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.28,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytokine production and migratory capacity.</text>
   <text y="522.079" x="62.361,70.857,74.853,77.85,82.854,87.354,92.358,95.859,98.856" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="522.079" x="102.033,109.809,113.805,116.055,116.982,120.978,125.478,129.474,131.976,136.476,140.472,144.468,148.968,151.218,152.145,158.148,160.398,161.325,165.321,169.317,171.819,174.321,176.571,177.498,180.999,185.499,189.999,193.5,197.496,199.998,202.248,203.175,207.171,211.671,218.673,223.173,227.673,231.174,233.676,236.178,238.68,243.18,247.68,249.93,250.857,254.853,259.353,263.853,266.103,267.03,271.026,275.526,278.028,282.528,287.028,289.53,294.03,298.026" svgx:width="0.94,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We analyzed B cell subset composition and cytokine </text>
   <text y="533.077" x="62.361,66.861,69.858,74.358,78.858,83.358,87.354,89.856,92.358,96.858,101.358,103.635,108.135,111.132,113.409,119.412,121.689,125.685,129.681,132.183,134.685,138.186,140.463,144.963,148.959,151.956,154.458,158.958,162.954,167.454,169.731,172.728,175.725,180.225,187.227,189.504,194.004,198.0,200.997,203.499,207.999,212.499,216.495,219.492,223.488,225.99,228.267,232.767,235.269,239.769,244.269,248.769,251.046,258.048,262.548,267.048,271.548,276.048,280.548,284.544,287.046,291.042,295.038,298.035" svgx:width="0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.78,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">production of B cells derived from peripheral blood mononuclear </text>
   <text y="544.075" x="62.361,66.357,70.353,72.855,75.357,78.858,81.162,84.159,87.156,91.656,98.658,100.971,107.973,112.473,114.975,117.477,119.979,124.479,126.981,130.977,133.281,136.782,140.778,143.28,147.276,150.273,154.773,158.274,160.776,164.277,166.581,171.081,175.077,177.579,180.081,184.077,188.577,191.079,194.58,196.884,201.384,205.884,210.384,214.38,217.377,219.69,224.694,227.196,231.696,236.196,240.696,243.198,245.7,252.702,257.202,261.702,264.015,266.517,269.514,273.51,277.506,280.008,287.01,291.006,295.506,298.008" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells from multiple sclerosis patients under Fingolimod treatment </text>
   <text y="555.073" x="62.361,64.863,69.363,71.568,75.564,80.064,87.066,91.566,95.562,98.559,101.061,104.562,109.062,113.562,115.767,118.269,122.769,124.974,129.474,133.974,136.476,139.473,143.469,147.465,149.967,153.963,158.463,160.668,167.67,172.17,174.672,177.174,179.676,184.176,186.678,190.674,192.879,196.38,200.376,202.878,206.874,209.871,214.371,217.872,220.374,223.875,226.08,230.58,234.576,237.078,239.58,243.576,248.076,250.578,254.079,256.284,260.28,264.78,269.28,271.485,275.985,279.981,283.977,286.479,288.981,293.481,297.981" svgx:width="0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in comparison to untreated multiple sclerosis patients and healthy </text>
   <text y="566.071" x="62.361,66.357,70.857,75.357,77.859,80.856,85.356,87.858,91.359,93.609,95.859,98.01,102.51,107.01,109.26,111.411,114.408,116.91,121.41,127.908,130.15800000000002,132.309,136.305,140.805,143.307,147.807,154.809,158.805,161.307,164.304,168.804,171.054,173.205,177.201,181.701,186.201,188.451,190.602,196.101,201.6,204.597,209.601,216.099,218.349,220.599,222.75,227.754,232.254,235.251,237.753,242.253,246.249,248.886,251.136,253.386,255.537,258.039,262.539,269.541,274.041,278.541,283.041,287.037,291.537,294.039,298.035" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.72,0.25,0.55,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.61,0.33,0.56,0.72,0.25,0.25,0.55,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controls, by flow cytometry and ELISA. Further, lymphocyte </text>
   <text y="577.069" x="62.361,69.363,71.865,76.365,79.362,83.358,85.86,88.362,92.862,97.362,99.981,103.977,107.973,110.97,115.47,118.971,122.472,125.091,129.591,132.588,135.09,142.092,146.088,149.085,153.585,156.204,160.704,165.204,172.206,176.202,180.702,183.321,187.821,190.818,194.814,197.316,201.816,204.435,211.437,213.939,217.935,220.932,225.432,229.932,233.928,237.429,241.425,245.925,248.427,252.423,255.42,258.039,262.035,266.535,271.035,275.535,278.037,282.537,286.533,289.035,291.537,295.533,298.035" svgx:width="0.78,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.78,0.28,0.44,0.33,0.5,0.5,0.44,0.39,0.44,0.5,0.28,0.44,0.33,0.25,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">migration across primary human brain microvascular endothelial </text>
   <text y="588.067" x="62.361,66.357,70.353,72.855,75.357,78.858,81.108,83.196,89.694,93.69,97.191,99.441,101.529,105.525,110.025,114.021,116.523,121.023,125.019,127.521,131.517,136.017,138.267,140.355,142.857,147.357,149.607,151.695,155.691,160.191" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells was evaluated in an </text>
   <text y="588.067" x="164.529,167.031,171.531,173.781,175.869,179.865,182.367,184.869,188.037" svgx:width="0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="588.067" x="192.537,194.787,196.875,199.377,202.374,206.37,210.87,214.371,221.373,223.875,228.375,231.372,235.368,237.87,240.372,244.872,249.372,251.622,253.71,257.706,261.207,264.708,268.704,273.204,275.454,277.542,282.042,286.542,291.042,295.038,298.035" svgx:width="0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.78,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> transmigration assay under </text>
   <text y="599.065" x="62.361,66.861,71.361,78.363,82.359,86.859,90.36,92.862,96.858,99.36,101.862,105.858,108.126,112.122,115.623,117.891,124.389,128.385,130.887,133.389,135.657,139.653,143.154,145.422,149.922,154.422,158.922,162.918,165.915,168.183,170.685,175.185,178.182,180.684,184.68,191.682,198.684,202.68,205.182,209.682,212.679,217.179,219.447,223.443,227.943,232.443,236.943,239.445,241.947,244.449,248.949,253.449,256.95,259.2,261.468,265.464,269.964,274.464,276.732,282.735,285.003,288.999,292.995,295.497,297.999" svgx:width="0.5,0.5,0.78,0.44,0.5,0.39,0.28,0.44,0.28,0.28,0.44,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">homeostatic as well as under inflammatory conditions, and B cell </text>
   <text y="610.063" x="62.361,65.862,70.362,74.862,78.363,82.359,84.861,88.362,90.612,92.718,99.216,103.212,106.209,110.205,112.455,114.561,118.557,123.057,127.053,129.555,134.055,138.051,140.553,144.549,149.049,151.299,153.405,155.907,160.407,162.657,164.763,170.766,175.77,180.774,183.024,185.13,189.126,193.626,198.126,200.376,202.482,206.982,210.978,213.975,216.477,220.977,225.477,229.473,232.47,236.466,238.968,241.218,243.324,247.824,250.326,254.826,259.326,263.826,266.076,268.182,272.682,277.182,279.432,281.538,284.535,287.037,291.537,298.035" svgx:width="0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">subsets were evaluated in CSF and peripheral blood by flow </text>
   <text y="621.061" x="62.361,66.357,70.857,73.359,77.859,84.861,88.857,91.359,94.356,98.271,100.521,103.293,108.297,110.799,115.299,119.295,121.797,124.299,128.214,130.464,133.236,136.233,140.229,144.729,149.229,151.731,155.727,158.229,162.729,165.726,170.226,172.998,179.001,181.773,185.769,189.765,192.267,194.769,197.541,200.538,203.535,207.531,212.031,216.531,220.527,225.027,229.023,231.525,235.521,239.022,241.794,248.292,252.288,255.285,259.281,262.053,266.049,270.549,273.546,276.543,280.539,283.041,287.037,289.539,293.535,298.035" svgx:width="0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.25,0.56,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytometry. Finally, regulatory B cell frequencies were correlated </text>
   <text y="632.059" x="62.361,68.859,71.361,73.863,78.363,80.613,85.113,89.109,92.106,96.102,103.104,107.1,109.602,113.598,116.595,120.096,122.346,126.846,129.843,132.093,136.593,139.095,142.596,146.592,150.588,154.089,158.085,160.335,163.836,166.338,170.334,174.834,177.336,179.838,182.34,184.842,188.757" svgx:width="0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with parameters of disease stability.</text>
   <text y="643.057" x="62.361,68.859,72.855,76.356,81.36,83.862,86.859,90.36,93.357" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="643.057" x="95.049,103.185,105.687,108.189,112.689,115.191,119.691,121.383,123.885,128.385,132.381,134.073,138.573,142.569,145.566,148.068,152.568,157.068,161.064,164.061,168.057,170.559,172.251,178.254,179.946,183.942,187.938,190.44,192.942,194.634,198.63,203.13,210.132,214.632,218.628,221.625,224.127,231.129,235.125,239.625,242.127,243.819,248.319,251.316,253.008,258.012,260.514,265.014,269.514,274.014,276.516,279.018,286.02,290.52,295.02" svgx:width="0.94,0.28,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Within the peripheral B cell compartment of Fingolimod-</text>
   <text y="654.055" x="62.361,64.863,67.86,71.856,75.852,78.354,82.35,86.85,89.1,91.494,95.994,99.99,102.492,104.994,108.99,113.49,115.992,119.493,121.743,123.993,126.387,128.889,133.389,137.385,139.635,142.029,146.529,149.526,154.026,158.526,163.026,166.023,168.525,171.027,175.527,180.027,182.277,184.671,189.171,192.168,194.418,196.812,199.809,203.805,208.305,212.805,215.307,219.303,221.805,226.305,229.302,233.802,236.052,238.446,244.449,246.699,249.093,253.089,257.085,259.587,262.089,265.59,267.84,270.234,273.231,279.234,285.732,290.232" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.33,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated patients, the proportion of regulatory B cells (CD38</text>
   <text y="651.583" x="294.716" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="654.103" x="298.016" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="665.101" x="62.36,68.363,74.861,79.361" svgx:width="0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD27</text>
   <text y="662.583" x="83.863" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">-</text>
   <text y="665.103" x="85.811,88.115,94.118,100.616,105.116" svgx:width="0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> CD24</text>
   <text y="662.583" x="109.619" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="665.103" x="112.918,115.222,121.225,127.723" svgx:width="0.25,0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> CD5</text>
   <text y="662.583" x="132.226" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="665.103" x="135.525,138.522,140.826,147.324,151.32,154.822,157.126,160.627,163.129,167.629,172.129,174.631,177.628,180.13,184.126,188.122,192.622,195.124,197.626,202.126,204.43,206.932,211.432,215.428,218.424,222.421,226.417,229.918,233.914,238.414,240.718,247.216,251.716,255.712,260.212,262.516,266.512,271.012,278.014,282.514,286.51,289.507,293.503,298.003" svgx:width="0.33,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.72,0.5,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) was significantly increased when compared </text>
   <text y="676.101" x="62.365,64.867,69.367,71.95,74.451,77.449,81.445,85.441,87.943,94.945,98.941,103.441,105.943,108.94,113.44,117.436,119.938,124.438,128.434,131.016,138.018,142.518,145.02,147.522,150.024,154.524,157.026,161.022,163.605,167.106,171.102,173.604,177.6,180.597,185.097,188.598,191.1,194.602,197.184,201.684,205.68,208.182,210.684,214.68,219.18,221.682,225.184,227.766,231.762,236.262,240.762,243.345,245.847,250.347,252.93,257.43,261.426,265.422,267.924,270.427,274.927,279.427,282.01,286.006,290.506,295.006" svgx:width="0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to treatment-naïve multiple sclerosis patients and to healthy con-</text>
   <text y="687.099" x="62.365,64.867,67.864,72.364,74.866,78.367,80.617,82.867,87.465,91.462,95.962,100.462,102.712,107.311,110.812,113.313,117.813,122.313,124.815,127.813,130.314,134.311,138.307,142.807,145.309,147.811,152.311,154.561,159.16,166.161,170.661,173.658,177.654,179.904,184.503,187.5,191.496,195.996,200.496,202.998,206.994,209.496,213.996,216.993,221.493,223.743,228.342,234.345,236.595,241.194,245.19,249.186,251.688,254.19,257.691,259.941,264.54,269.04,272.038,276.538,281.038,285.538,289.534,293.53,298.03" svgx:width="0.28,0.33,0.5,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trols, and significantly more regulatory B cells produced </text>
   <text y="698.097" x="62.365,65.362,69.862,72.364,76.36,79.357,81.859,85.855,90.355,94.855,97.357,101.857,104.854,109.354,113.854,116.104,118.354,120.01,125.014,127.516,132.016,136.516,141.016,143.518,146.02,153.021,157.521,162.021,164.271,165.928,168.43,171.426,175.423,179.419,181.921,188.923,192.919,197.419,199.921,202.171,203.827,207.823,212.323,216.823,220.819,225.319,229.315,233.311,237.811,240.061,241.717,244.219,248.719,252.715,254.965,256.621,260.617,264.613,269.113,273.109,277.105,279.607,282.109,286.609,288.859,290.515,295.015,298.012" svgx:width="0.33,0.5,0.28,0.44,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.33,0.5,0.5,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Interleukin-10. Fingolimod treatment enhanced the capacity of </text>
   <text y="709.095" x="62.365,65.362,69.358,73.858,78.358,80.86,84.856,87.358,91.858,94.855,99.355,101.542,107.545,109.731,113.728,117.724,120.226,122.728,126.229,128.415,130.917,135.417,137.604,140.106,143.103,147.099,151.599,155.1,162.102,164.604,169.104,172.101,176.097,178.599,182.595,184.782,188.778,192.774,195.771,200.271,203.772,207.273,209.46,213.96,216.957,220.953,223.455,227.955,230.142,234.138,238.638,243.138,247.638,250.14,254.64,258.636,261.138,263.641,267.637,270.139,272.326,276.322,280.318,282.82,285.322,288.823,291.01,293.512,298.012" svgx:width="0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.5,0.39,0.78,0.28,0.5,0.33,0.44,0.28,0.44,0.25,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">regulatory B cells to transmigrate across brain endothelial cells in </text>
   <text y="720.093" x="62.365,66.361,70.861" svgx:width="0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">an </text>
   <text y="720.093" x="73.408,75.91,80.41,83.407,87.403,89.905,92.407,95.575" svgx:width="0.28,0.5,0.33,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in-vitro</text>
   <text y="720.093" x="100.075,102.621,109.623,114.123,118.623,122.619,125.121,127.668,132.168,135.165,137.712,140.214,144.714,148.71,151.257,155.757,158.259,162.759,167.259,171.759,174.756,179.256,182.253,186.249,188.751,193.251,196.248,200.748,204.744,207.741,210.738,213.24,217.236,219.738,221.988,224.535,227.532,232.032,234.579,237.081,239.583,244.083,248.079,250.626,257.124,259.626,262.128,266.628,269.175,271.677,276.177,278.679,282.18,284.43,286.977,289.479,293.979,297.975" svgx:width="0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.44,0.33,0.33,0.28,0.44,0.33,0.25,0.25,0.33,0.5,0.25,0.28,0.28,0.5,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> model of the blood-brain-barrier. In line with this, the </text>
   <text y="731.091" x="62.365,68.368,73.371,78.375,80.877,85.377,87.879,92.379,96.879,101.379,103.026,106.023,110.02,112.521,115.023,119.523,121.171,125.671,128.667,130.314,132.816,137.316,139.818,143.814,146.316,147.964,153.967,155.614,159.61,163.606,166.108,168.61,172.111,173.758,177.754,182.254,186.754,188.401,191.398,195.394,199.894,204.394,206.896,210.892,213.394,217.894,220.891,225.391,227.038,233.041,234.688,238.684,242.68,245.182,247.684,251.185,252.832,259.33,263.326,266.827,268.474,271.975,274.477,277.474,281.974,286.474,290.974,293.476,297.976" svgx:width="0.67,0.56,0.56,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.33,0.5,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CSF/blood ratio of total B cells and regulatory B cells was strongly </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 237.300 L333.770 237.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 654.300 L359.240 654.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,312.518,317.018,321.014,324.011,328.007,332.003,335.504,339.5,344.0,346.25,350.651,355.151,359.651,361.901,366.302,371.306,373.808,378.308,382.808,387.308,389.81,392.312,399.314,403.814,408.314,410.564,414.965,417.467,420.464,424.46,428.456,430.958,437.96,441.956,446.456,448.958,451.208,453.458,457.859,461.855,466.355,470.855,473.105,477.506,482.006,486.002,488.504,491.006,495.002,499.502,502.004,505.505,507.755,512.156,516.152,520.652,525.152,527.654,532.154,534.656,537.158,541.154,545.654" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased by Fingolimod treatment, and patients exhibited </text>
   <text y="88.101" x="310.016,312.518,317.018,321.014,324.011,328.007,332.003,335.504,339.5,344.0,346.25,347.114,350.111,354.107,358.607,363.107,365.609,369.605,372.107,376.607,379.604,384.104,386.354,387.218,393.221,395.471,396.335,400.331,404.327,406.829,409.331,411.581,412.445,415.442,418.439,422.435,426.935,431.435,435.431,439.931,443.927,446.429,450.425,453.926,456.176,457.04,459.542,464.042,466.292,467.156,469.658,474.158,478.154,480.404,481.268,487.271,492.275,496.559,498.809,501.059,501.923,506.927,509.429,513.929,517.925,520.427,522.929,526.844,529.094,531.344,532.208,536.204,538.706,542.702" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.56,0.56,0.25,0.25,0.55,0.56,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased regulatory B cell frequencies in the CSF. Finally, ele-</text>
   <text y="99.099" x="310.016,314.516,318.512,321.014,325.01,329.51,332.156,335.153,339.149,343.649,348.149,350.651,354.647,357.149,361.649,364.646,369.146,371.792,377.795,380.441,384.437,388.433,390.935,393.437,396.083,399.08,402.077,406.073,410.573,415.073,419.069,423.569,427.565,430.067,434.063,437.564,440.21,442.712,447.212,449.858,452.36,456.86,460.856,463.502,468.002,471.998,474.995,477.497,481.997,486.497,490.493,493.49,497.99,500.636,504.137,506.639,511.139,515.639,518.141,521.138,523.64,527.636,531.632,536.132,538.634,541.136,545.636" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vated regulatory B cell frequencies in the periphery significantly </text>
   <text y="110.097" x="310.016,314.012,318.512,321.509,324.506,328.502,331.004,335.0,337.502,341.498,345.998,348.248,350.354,356.852,359.354,361.856,366.356,368.606,370.721,374.717,377.219,379.721,384.221,386.723,390.719,394.715,397.217,399.467,401.573,405.569,410.069,414.569,416.819,418.934,423.434,427.43,430.427,434.423,438.419,440.921,443.423,447.923,450.425,454.421,458.417,460.919,463.169,465.275,469.775,472.277,475.778,479.774,483.77,487.271,491.267,493.517,495.623,499.124,501.626,505.622,510.122,512.624,515.126,517.628,520.13,524.045,526.295,528.545,530.651,533.153,537.653,542.153,545.654" svgx:width="0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.55,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">correlated with clinical and paraclinical disease stability, thus </text>
   <text y="121.095" x="310.016,314.516,319.016,321.518,326.018,328.52,331.022,335.522,340.022,342.272,344.045,346.547,351.047,353.297,355.07,359.066,361.316,363.089,366.086,370.586,375.086,379.082,381.584,384.086,388.586,393.086,397.082,399.584,401.834,403.607,406.604,410.6,413.102,417.098,421.598,425.594,430.094,434.09,438.086,440.336,442.109,446.609,449.606,451.856,453.629,456.626,460.622,465.122,469.622,472.124,476.12,478.622,483.122,486.119,490.619,492.869,494.642,500.645,502.895,504.668,508.664,512.66,515.162,517.664,521.165,523.415,525.188,529.688,534.188,538.688,542.684,545.681" svgx:width="0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pointing to a functional relevance of regulatory B cells under </text>
   <text y="132.093" x="310.016,315.02,317.522,322.022,326.522,331.022,333.524,336.026,343.028,347.528,352.028,354.278,356.78,359.777,363.773,367.769,370.271,377.273,381.269,385.769,388.271" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod treatment.</text>
   <text y="143.091" x="310.016,316.649,321.284,326.423,330.554,333.191,338.33,341.966,344.603,349.238,354.377,358.013,361.145" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="143.091" x="363.386,368.39,372.521,377.156,381.287,385.922,388.163,390.8,395.435,400.07,404.201,406.838,411.473,415.604,418.376,420.761,423.002,425.639,430.274,434.405,438.041,442.172,444.413,449.048,453.179,455.816,459.947,462.188,466.823,471.458,474.095,478.73,481.367,483.608,486.245,490.88,493.121,497.252,499.493,504.128,508.763,513.398,517.529,520.166,522.407,526.538,531.173,535.808,538.049,542.18,545.681" svgx:width="0.61,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Taken together, these data point to a novel and as </text>
   <text y="154.089" x="310.016,314.651,318.782,321.419,324.254,328.889,333.524,336.656,340.787,344.918,349.553,354.188,358.823,361.46,365.591,369.722,374.357,377.192,380.324,384.959,387.596,391.727,394.562,399.197,402.329,405.164,410.303,412.94,417.575,422.21,426.845,429.482,432.119,439.256,443.891,448.526,451.361,453.998,458.633,461.468,465.599,470.234,473.366,476.498,480.629,484.76,487.397,490.034,494.669,499.304,502.139,506.774,509.906,512.741,515.378,522.515,527.15,531.281,533.918,537.05,541.181,545.681" svgx:width="0.5,0.44,0.28,0.25,0.5,0.5,0.33,0.44,0.44,0.5,0.5,0.5,0.28,0.44,0.44,0.5,0.25,0.33,0.5,0.28,0.44,0.25,0.5,0.33,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">yet unrecognized role of Fingolimod in correction of impaired </text>
   <text y="165.087" x="310.016,316.154,318.251,322.382,326.513,329.15,331.787,333.884,337.016,341.651,346.286,350.417,353.054,355.691,360.326,364.961,368.597,370.694,373.331,377.966,380.063,387.2,391.835,394.472,397.109,399.746,404.381,407.018,411.149,413.246,416.882,421.013,423.65,427.781,430.913,435.548,439.184,441.821,445.457,447.554,452.189,456.824,458.921,463.052,467.687,472.322,476.453,481.088,485.219,487.856,492.491,497.126,499.223,502.355,506.486,511.121,515.756,518.393,522.524,525.161,529.796,532.928,537.563,539.66,545.663" svgx:width="0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B cell functions in multiple sclerosis by enhancing regulatory B </text>
   <text y="176.085" x="310.016,314.147,318.278,320.915,323.552,327.188" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells.</text>
   <text y="203.085" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P953</text>
   <text y="214.083" x="310.016,316.514,319.016,322.013,326.513,334.01,336.512,341.516,343.766,350.264,354.764,357.014,361.514,366.518,374.015,376.517,381.521,384.023,387.524,390.521,394.517,399.017,402.014,404.516,409.016,414.02,416.27,419.267,423.767,426.017,434.513,439.517,441.767,446.771,451.271,454.268,456.77,460.766,465.77,468.767,472.268,474.518,477.02,481.016,485.516,490.52,494.021,496.271,499.268,503.768" svgx:width="0.72,0.28,0.33,0.5,0.83,0.28,0.56,0.25,0.72,0.5,0.25,0.5,0.56,0.83,0.28,0.56,0.28,0.39,0.33,0.44,0.5,0.33,0.28,0.5,0.56,0.25,0.33,0.5,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.28,0.44,0.5,0.56,0.39,0.25,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Vitamin D3 administration to MS patients leads to </text>
   <text y="225.081" x="310.016,312.518,317.522,321.518,325.514,329.51,334.01,337.511,341.507,346.511,348.761,352.262,356.258,360.254,365.258,372.755,375.005,377.507,381.503,386.003,389.999,392.501,396.002,398.252,402.752,405.749,407.999,414.002,421.004,426.503,429.5,434.504,438.5,441.497" svgx:width="0.28,0.56,0.44,0.44,0.44,0.5,0.39,0.44,0.56,0.25,0.39,0.44,0.44,0.56,0.83,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.67,0.78,0.61,0.33,0.56,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">increased serum levels of TGF-beta</text>
   <text y="236.079" x="310.016,313.517,315.767,322.265,324.767,329.267" svgx:width="0.39,0.25,0.72,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J Åivo</text>
   <text y="233.583" x="333.767" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="236.103" x="336.691,338.941,341.191,347.689,349.939,356.437,360.433,364.933,369.433,371.935,376.435,380.431" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.5,0.28,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Hänninen</text>
   <text y="233.583" x="384.931" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="236.103" x="387.856,390.106,392.356,395.857,398.107,401.104,403.606,408.106,412.606,416.602" svgx:width="0.25,0.25,0.39,0.25,0.33,0.28,0.5,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Ilonen</text>
   <text y="233.583" x="421.102" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="236.103" x="424.027,426.277,428.527,436.528,438.778,443.782,448.282,450.784,453.286,457.786,460.783,467.281,471.277,475.777,480.277,482.779,487.279,491.275" svgx:width="0.25,0.25,0.89,0.25,0.56,0.5,0.28,0.28,0.5,0.33,0.72,0.44,0.5,0.5,0.28,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Soilu-Hänninen</text>
   <text y="233.583" x="495.774" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="244.581" x="310.013" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="247.103" x="312.941,317.945,322.445,325.946,329.942,334.442,336.692,343.19,347.69,350.192,354.188,358.184,361.685,365.186,367.688,370.19,374.186,376.436,382.934,387.434,390.935,395.435,397.937,400.439,404.939,407.441,409.691,411.941,417.944,421.94,426.44,429.941,434.441,436.943,441.443,445.943,449.939,452.189,454.439,459.443,463.943,467.444,471.44,475.94,478.19,480.44,485.939,488.441,492.941,495.443,499.943,504.443,508.943,511.193" svgx:width="0.56,0.5,0.39,0.44,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.39,0.44,0.5,0.25,0.25,0.61,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Turku University Hospital, Neurology, Turku, Finland, </text>
   <text y="255.583" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="258.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,366.941,371.441,374.942,378.938,383.438,385.688,387.938,394.436,398.432,402.932,407.432,410.933,413.435,419.933,423.929,428.429,430.931,433.181,437.681,440.183,442.433,448.436,450.938,453.44,457.94,460.442,464.438,468.938,471.44,473.69,481.187,483.689,487.685,491.186,495.686,500.186,502.688,507.188,509.69,514.19,518.69,522.686" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.5,0.39,0.44,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Turku, Department of Clinical Microbiology </text>
   <text y="269.101" x="310.016,314.516,319.016,323.516,325.766,328.763,335.261,341.759,346.259,350.759,355.259,357.761,362.261,366.761,370.757,373.007,375.257,380.261,384.761,388.262,392.258,396.758,399.008,401.258,406.757,409.259,413.759,416.261,420.761,425.261,429.761,432.011" svgx:width="0.5,0.5,0.5,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.39,0.44,0.5,0.25,0.25,0.61,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">and Immunology, Turku, Finland, </text>
   <text y="266.583" x="434.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="269.103" x="437.185,443.683,448.183,450.685,454.681,458.677,462.178,465.679,468.181,470.683,474.679,476.929,481.429,483.931,486.181,491.185,495.685,499.186,503.182,507.682,509.932" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.5,0.39,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Turku, </text>
   <text y="280.101" x="310.015,313.012,319.51,326.008,330.508,335.008,339.508,344.008,348.004,352.504,356.5,359.002,361.504,365.5,369.001,371.251,376.255,380.755,385.255,389.755,393.256,397.756,400.258,404.758,408.259,412.255,414.505,416.755,421.759,426.259,429.76,433.756,438.256,440.506,442.756,448.255,450.757,455.257,457.759,462.259,466.759" svgx:width="0.33,0.72,0.72,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.39,0.25,0.56,0.5,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.44,0.25,0.25,0.56,0.5,0.39,0.44,0.5,0.25,0.25,0.61,0.28,0.5,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Immunogenetics Laboratory, Turku, Finland</text>
   <text y="307.101" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="307.101" x="362.926,368.884,371.386,373.888,377.884,384.886,387.388,391.888,394.453,400.951,403.516,406.018,409.519,412.084,416.08,420.58,423.145,427.141,431.641,436.141,438.643,441.64,446.14,450.64,457.642,461.638,466.138,468.64,472.636,475.138,477.703,480.7,483.202,486.703,491.203,493.768,496.765,500.761,504.757,507.259,511.759,514.756,517.321,520.318,524.818,527.815,530.38,538.381,543.385,545.635" svgx:width="0.72,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Vitamin D is an environmental risk factor for MS. </text>
   <text y="318.099" x="310.015,313.012,315.514,317.764,318.52,323.02,327.016,330.517,332.767,333.532,336.034,343.036,350.038,354.538,359.038,363.538,370.54,375.04,379.54,384.04,386.542,390.538,393.04,397.54,400.537,405.037,407.287,408.043,412.039,414.874,417.871,421.867,425.863,428.365,431.866,434.116,436.366,437.122,439.624,444.124,448.12,450.622,455.122,459.622,462.124,466.624,471.124,473.374,474.13,478.63,481.627,486.127,493.129,497.629,500.131,502.633,507.133,511.633,513.883,514.648,519.148,522.145,524.989,529.66,532.657,536.653,540.649,543.151,545.653" svgx:width="0.33,0.28,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.78,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">It has immunomodulatory effects, including promotion of T-cell </text>
   <text y="329.097" x="310.015,314.515,317.017,319.852,322.849,326.845,329.842,333.838,338.338,340.84,343.342,347.338,349.84,352.342,356.842,361.342,363.592,364.528,367.03,371.53,374.032,378.532,380.782,381.556,386.227,389.224,392.221,396.217,400.717,405.217,407.719,411.715,414.217,418.717,421.714,426.214,428.464,429.4,433.396,437.392,439.894,442.396,445.897,448.147,450.397,451.333,457.831,462.331,464.833,468.829,473.329,475.579,476.515,481.015,484.012,488.512,493.012,497.512,501.508,505.504,507.754,508.69,511.687,515.683,520.183,524.683,527.185,531.181,533.683,538.183,541.18,545.68" svgx:width="0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.61,0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">differentiation into T-regulatory cells, which produce regulatory </text>
   <text y="340.095" x="310.015,314.011,318.511,321.013,325.513,330.013,332.515,337.015,341.011,344.512,346.762,348.652,351.154,355.654,359.65,362.152,366.652,371.152,373.654,378.154,382.654,384.904,386.632,392.131,398.629,403.633,408.214,410.464,412.714,414.604,417.601,422.101,426.097,429.094,433.09,437.086,440.587,443.089,447.589,452.089,454.339,456.229,459.73,463.726,466.723,471.223,478.225,480.475,482.365,486.865,489.367,491.869,495.865,502.867,505.369,509.869,512.119,514.009,520.507,522.757,524.647,527.149,531.145,535.645,539.641,542.143,545.644" svgx:width="0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.51,0.25,0.25,0.55,0.33,0.5,0.44,0.33,0.44,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.55,0.72,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytokines including TGFβ. Increasing serum vitamin D levels </text>
   <text y="351.093" x="310.015,314.515,318.511,323.011,327.007,329.257,332.029,336.529,340.525,344.521,349.021,351.271,354.043,358.039,361.54,365.041,369.541,373.537,376.039,380.035,382.537,386.533,391.033,393.283,396.055,402.553,405.055,407.557,412.057,414.307,417.079,421.579,425.575,429.571,432.568,436.564,440.56,444.061,448.057,452.557,454.807,457.579,462.079,464.581,468.082,472.078,476.074,479.575,483.571,485.821,488.593,492.589,496.585,499.087,501.589,506.089,508.591,511.093,515.593,517.843,520.615,523.117,527.617,529.867,532.639,540.64,545.644" svgx:width="0.5,0.44,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">have been associated with decreased disease activity in MS </text>
   <text y="362.091" x="310.015,314.515,318.511,321.013,323.515,327.511,332.011,334.513,338.014,340.264,342.514,343.198,347.698,352.198,354.7,356.95,357.634,360.136,364.636,368.632,371.629,375.625,377.875,378.559,382.555,385.552,389.548,391.798,392.482,396.982,401.482,403.984,408.484,410.734,411.418,414.415,418.411,424.909,427.159,427.843,431.344,433.846,438.346,442.846,445.348,449.344,452.845,455.095,455.779,459.775,464.275,468.775,472.771,476.767,479.764,484.264,486.766,491.266,495.766,498.016,498.7,501.202,505.702,509.698,511.948,512.632,515.134,522.136,529.138,533.638,538.138,542.638" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.44,0.72,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients, but there are only few studies concerning the immuno-</text>
   <text y="373.089" x="310.015,312.517,317.017,321.517,324.019,328.015,332.011,334.513,336.763,340.759,343.594,346.591,350.587,354.583,357.085,360.586,362.836,367.336,370.333,372.583,377.083,379.585,382.087,386.083,393.085,395.587,400.087,402.337,408.835,411.085,414.586,419.086,423.586,428.086,430.588,434.584,441.586,445.582,450.082,452.584,456.58,459.082,461.584,466.084,470.584,472.834,475.336,479.836,482.086,490.087,495.091" svgx:width="0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.25,0.39,0.5,0.5,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">logical effects of vitamin D supplementation in MS.</text>
   <text y="384.087" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="384.087" x="357.211,360.208,364.708,366.958,368.416,370.918,375.418,377.92,381.421,383.671,385.129,388.63,391.132,395.632,400.132,404.632,406.882,408.34,414.838,418.834,421.084,422.542,425.044,429.544,434.044,438.04,441.541,444.043,446.545,451.045,455.041,457.543,461.539,466.039,468.289,469.747,472.249,476.749,480.745,482.995,484.453,488.449,491.284,494.281,498.277,502.273,504.775,507.025,508.483,512.983,515.98,518.23,519.688,526.186,530.182,534.178,538.678,541.18,545.68" svgx:width="0.33,0.5,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.44,0.44,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In this study we investigated the effect of weekly </text>
   <text y="395.085" x="310.015,313.516,318.016,322.516,327.016,329.518,333.514,340.516,344.512,349.012,351.514,355.51,358.012,360.514,365.014,369.514,371.332,375.832,378.829,380.647,385.147,387.649,390.151,394.147,401.149,403.651,408.151,409.969,416.467,420.967,422.785,427.285,430.282,432.1,436.6,439.102,443.098,447.094,451.09,455.59,460.09,461.908,466.408,470.908,472.726,476.227,480.223,483.22,487.72,494.722,496.54,499.042,503.038,507.538,511.534,514.036,517.537,519.355,523.855,526.852,528.67,535.672,540.172,542.674" svgx:width="0.39,0.5,0.5,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.78,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">supplementation of vitamin D3 or placebo on serum levels of mul-</text>
   <text y="406.083" x="310.015,312.517,315.019,319.519,322.021,326.017,328.267,332.263,336.763,339.265,343.765,348.265,350.767,355.267,359.263,362.764,365.014,367.516,372.016,374.266,378.766,382.762,385.264,387.766,391.762,396.262,398.764,402.265,404.515,411.013,413.515,416.017,420.517,422.767,425.764,429.76,432.262,436.258,440.758,444.259,446.761,451.261,455.761,458.011,461.008,465.004,472.006,474.508,477.01,479.512,482.014,486.514,491.014,493.264,501.265,506.269" svgx:width="0.28,0.28,0.5,0.28,0.44,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tiple cytokines in patients with relapsing remitting MS.</text>
   <text y="417.081" x="310.015,318.511,322.507,325.504,330.508,335.008,340.012,343.513,346.51" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="417.081" x="349.093,354.592,359.092,363.088,365.671,369.172,371.674,376.174,380.674,385.174,387.757,394.255,398.251,401.752,404.335,408.331,412.831,417.331,421.831,426.331,430.327,432.829,436.825,441.325,443.908,448.408,452.908,455.491,457.993,462.493,466.489,469.072,473.572,477.568,480.07,482.572,486.568,491.068,493.57,496.153,500.149,504.649,509.149,513.649,516.646,519.148,521.731,526.231,529.228,531.649,537.148,541.648,545.644" svgx:width="0.61,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.5,0.33,0.25,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The study was conducted on the patient cohort of The </text>
   <text y="428.079" x="310.015,315.019,317.521,322.021,326.521,329.023,332.524,337.024,338.941,344.899,347.401,349.903,353.899,360.901,363.403,367.903,369.982,376.48,378.559,382.06,384.562,389.062,393.562,397.477,399.727,401.311,407.809,410.311,412.813,414.892,419.392,423.388,425.89,428.392,432.388,436.888,439.39,442.891,444.97,451.468,455.464,458.461,462.457,464.536,469.036,472.537,475.039,479.539,484.039,486.118,489.115,494.119,500.617,503.614,508.114,512.11,514.612,518.608,521.605,526.105,530.605,532.684,536.68,541.18,545.68" svgx:width="0.56,0.28,0.5,0.5,0.28,0.39,0.5,0.25,0.72,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Finnish Vitamin D study. All patients were using IFN-beta-1b and </text>
   <text y="439.077" x="310.015,316.513,320.509,323.506,327.502,330.319,333.316,337.312,341.812,346.312,350.812,357.814,360.316,364.312,368.308,372.808,375.625,378.127,382.627,385.444,389.44,393.94,398.44,401.437,405.937,410.437,413.254,415.756,418.753,422.749,426.745,429.247,436.249,440.245,444.745,447.247,450.064,456.562,459.064,461.566,466.066,468.883,472.879,475.381,477.883,482.383,486.379,489.376,492.193,496.189,500.689,505.189,507.691,511.687,515.683,519.679,522.181,526.177,528.679,531.676,535.672,538.669,543.169,545.671" svgx:width="0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.28,0.44,0.44,0.44,0.28,0.44,0.28,0.33,0.44,0.33,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were randomized to add-on treatment with either cholecalciferol </text>
   <text y="450.075" x="310.015,314.515,319.015,323.515,328.015,332.515,335.512,342.01,344.512,351.01,355.006,359.002,363.502,365.338,369.838,372.835,374.671,379.171,381.673,385.669,389.665,393.661,398.161,402.661,404.911,406.747,412.75,417.25,421.75,425.746,429.742,434.242,436.744,439.741,443.737,446.239,448.741,453.241,457.741,461.242,463.078,467.578,470.575,472.411,477.91,484.408,489.079,490.915,493.912,499.411,505.909,510.913,513.91,518.41,522.406,524.908,528.904,531.901,536.401,540.397,543.394,545.644" svgx:width="0.5,0.5,0.5,0.5,0.5,0.33,0.72,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.67,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.61,0.72,0.56,0.25,0.33,0.61,0.72,0.56,0.33,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">20000IU/week or placebo. Concentrations of LAP (TGF-beta-1a), </text>
   <text y="461.073" x="310.015,313.012,319.51,324.514,327.511,331.489,333.739,335.989,336.691,339.688,345.187,348.184,352.684,354.934,357.184,357.886,360.883,366.049,368.299,369.001,373.501,378.001,384.499,386.749,388.999,389.701,392.698,398.197,401.194,405.694,407.944,410.194,410.896,413.893,419.392,422.389,426.889,429.139,431.389,432.082,435.079,440.578,443.575,448.075,450.325,452.575,453.277,456.274,461.773,464.77,469.27,471.52,473.77,474.472,477.469,482.968,485.965,490.465,494.965,497.215,499.465,500.158,503.155,508.654,511.651,516.151,520.651,522.901,525.691,531.19,537.688,542.692,545.689" svgx:width="0.33,0.72,0.56,0.33,0.44,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.25,0.55,0.5,0.5,0.72,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.25,0.61,0.72,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">INF-γ, IL-2, IL 17A, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, TNF- </text>
   <text y="472.071" x="310.015,314.011,316.513,321.013,325.513,329.509,332.371,336.367,340.867,345.367,348.229,351.226,356.725,359.722,364.222,368.803,371.665,378.163,382.159,385.156,389.152,392.014,396.514,400.51,403.012,407.008,410.005,417.007,419.509,424.009,428.005,432.505,435.367,439.363,441.865,444.727,448.228,452.224,455.221,459.217,463.213,467.713,470.215,474.715,479.215,482.077,486.073,490.573,495.073,497.935,501.931,504.433,507.295,511.795,516.295,519.157,526.159,530.659,535.159,537.661,542.161,545.662" svgx:width="0.44,0.28,0.5,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.51,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.44,0.28,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alpha and IL-1β were determined at screening and at 12 months </text>
   <text y="483.069" x="310.015,314.515,318.016,320.518,325.018,329.518,331.768,335.764,340.264,347.266,354.268,358.264,361.261,365.257,367.759,371.755,374.257,376.507,379.504,382.006,386.506,391.006,394.003,397.999,401.5,405.496,409.492,413.992,416.494,418.744,423.244,427.24,431.236,435.736,437.986,440.488,447.49,454.492,458.992,463.492,467.992,471.988,475.489,478.99,482.986,487.486,489.736,494.236,496.738,499.24,502.741" svgx:width="0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.78,0.78,0.44,0.33,0.44,0.28,0.44,0.28,0.25,0.33,0.28,0.5,0.5,0.33,0.44,0.39,0.44,0.44,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">using commercial fluorescent bead immunoassay kits.</text>
   <text y="494.067" x="310.015,316.513,320.509,324.01,329.014,331.516,334.513,338.014,341.011" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="494.067" x="343.513,349.012,355.51,360.181,362.683,365.68,371.179,377.677,382.681,385.678,390.178,394.174,396.676,400.672,403.669,408.169,412.165,415.162,417.664,420.166,424.162,428.662,432.658,435.16,438.661,441.163,443.665,448.165,452.161,455.158,459.154,463.15,466.651,470.647,475.147,477.649,481.15,483.652,488.152,492.652,495.154,498.151,500.653,504.649,508.645,513.145,515.647,518.149,522.649,525.151,527.653,532.153,534.655,537.157,541.657,545.653" svgx:width="0.61,0.72,0.56,0.25,0.33,0.61,0.72,0.56,0.33,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.33,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LAP (TGF-beta-1a) levels increased significantly in the </text>
   <text y="505.065" x="310.015,314.515,317.017,319.519,323.515,330.517,333.019,337.519,340.138,346.636,349.255,351.757,354.754,358.75,362.746,365.248,369.244,373.744,376.363,380.863,383.86,388.36,392.86,397.36,399.979,402.976,405.973,410.473,417.475,420.094,424.09,426.709,433.711,437.707,441.703,446.203,448.822,453.322,456.319,458.938,463.438,467.938,470.557,473.554,478.558,484.057,486.676,490.843,495.343,498.34,500.959,505.459,512.461,516.961,519.463,521.965,524.467,527.086,529.588,534.088,536.707,541.207,545.707" svgx:width="0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.33,0.56,0.61,0.25,0.5,0.5,0.33,0.25,0.5,0.78,0.5,0.28,0.28,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vitamin D treated group from a mean of 47 (SE 11) nmol/l to 55 </text>
   <text y="516.063" x="310.015,313.012,318.016,323.515,326.413,330.913,335.413,338.41,341.308,345.808,352.81,357.31,359.812,362.314,364.816,367.714,370.216,374.716,377.614,382.114,386.614,389.512,396.514,401.014,405.514,408.016,412.516,416.017,418.915,421.912,426.412,431.488,435.988,438.238,442.738,447.238,451.738,456.238,459.235,461.485,464.383,469.387,471.889,475.885,479.881,483.877,488.377,492.877,495.775,498.277,501.274,505.27,509.266,511.768,518.77,522.766,527.266,529.768,532.666,537.166,541.162,545.662" svgx:width="0.33,0.56,0.61,0.25,0.5,0.5,0.33,0.25,0.5,0.78,0.5,0.28,0.28,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(SE 14) nmol/l in 12 months (p=0,0249). Placebo treatment had </text>
   <text y="527.061" x="310.015,314.515,319.015,321.265,323.776,327.277,329.779,334.279,338.779,341.281,344.278,346.78,350.776,354.772,359.272,361.774,364.024,366.535,370.531,373.366,376.363,380.359,384.355,386.857,389.107,391.618,396.118,400.618,402.868,405.379,410.878,417.376,422.047,424.297,426.808,429.31,433.306,437.806,441.802,444.304,447.805,450.055,452.305,454.654,460.153,464.653,468.649,470.899,473.41,475.912,479.908,484.408,488.404,490.906,494.407,496.657,499.168,503.668,506.665,508.915,511.426,513.928,518.428,522.424,524.674,527.185,531.685,534.187,538.687,542.683,545.68" svgx:width="0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">no significant effect on LAP levels. The levels of the other </text>
   <text y="538.059" x="310.015,314.011,318.511,321.013,325.513,330.013,332.515,337.015,341.011,344.512,346.762,351.262,353.764,358.264,360.514,365.014,369.514,372.016,374.266,378.262,382.762,386.758,391.258,395.758,399.754,402.004,405.505,408.007,412.507,417.007,419.509,422.506,425.008,429.004,433.0,437.5,440.002,442.504,447.004,449.254,451.756,456.256,458.506,462.502,465.004,467.506,472.006,476.002,478.999,481.249,485.749,488.746,493.246,497.746,502.246" svgx:width="0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytokines did not change significantly in either group.</text>
   <text y="549.057" x="310.015,316.513,321.013,326.017,330.013,332.515,337.519,341.02,343.522,348.022,353.026,356.527,359.524" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="549.057" x="364.816,372.592,376.588,378.838,381.88,385.381,389.881,394.381,400.879,404.875,409.375,411.625,414.667,417.169,421.669,425.665,428.662,432.658,436.654,440.155,444.151,448.651,450.901,453.781,459.28,465.778,470.782,473.779,478.279,482.275,484.777,488.773,491.023,494.065,496.567,500.563,505.063,509.059,511.561,515.062,517.312,520.354,522.856,527.356,529.606,532.648,540.649,545.653" svgx:width="0.94,0.44,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.61,0.72,0.56,0.33,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We showed increased TGF-beta levels in MS </text>
   <text y="560.055" x="310.015,314.515,318.511,321.013,323.515,327.511,332.011,334.513,338.014,340.813,343.315,346.312,350.308,354.304,356.806,360.802,365.302,368.101,374.599,377.101,379.603,384.103,386.902,391.402,393.904,396.406,400.402,407.404,409.906,414.406,417.205,423.703,428.203,430.453,433.252,439.75,444.25,447.247,450.046,453.043,457.039,460.54,465.04,467.542,470.044,473.545,476.344,479.845,484.345,488.845,493.345,497.845,500.842,503.344,506.143,510.139,514.639,519.139,526.141,530.137,534.637,537.139,541.135,545.635" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.5,0.25,0.25,0.72,0.5,0.33,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.25,0.44,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients treated with vitamin D3. Our results support augmented </text>
   <text y="571.053" x="310.015,313.012,317.008,321.508,326.008,328.51,332.506,335.008,339.508,342.505,347.005,349.84,355.177,357.427,358.174,362.17,366.166,368.668,371.17,373.42,374.167,377.164,381.664,386.164,390.16,392.662,395.164,399.664,404.164,406.414,407.161,409.663,414.163,416.413,417.16,425.161,430.165,432.415,433.162,437.662,441.658,444.16,446.662,450.658,455.158,457.66,461.161,463.411,464.158,467.659,472.159,476.659,481.159,483.661,487.657,494.659,498.655,503.155,505.657,509.653,514.153,516.403,517.15,521.65,526.15,528.4,529.147,533.647,536.149,538.651,542.647" svgx:width="0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">regulatory T cell function in MS patients supplemented by vita-</text>
   <text y="582.051" x="310.015,317.017,319.519,324.019,326.269,332.767,337.267" svgx:width="0.78,0.28,0.5,0.25,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">min D3.</text>
   <text y="609.051" x="310.015,315.514,320.014,324.514" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P954</text>
   <text y="620.049" x="310.015,316.513,320.509,325.513,330.517,334.513,337.51,340.012,344.512,349.516,351.766,356.266,361.27,366.274,368.524,372.52,376.516,380.512,385.012,390.016,393.517,396.514,399.016,402.013,407.017,410.014,412.516,417.016,422.02,424.27,428.77,431.767,434.017,440.02,443.017,447.013,451.009,453.511,456.013,459.514,461.764,464.266,469.27,471.52,476.524,480.52,484.516,487.018,492.022,497.026,501.022,505.018,509.518,512.02" svgx:width="0.72,0.44,0.56,0.56,0.44,0.33,0.28,0.5,0.56,0.25,0.5,0.56,0.56,0.25,0.44,0.44,0.44,0.5,0.56,0.39,0.33,0.28,0.33,0.56,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.56,0.25,0.56,0.44,0.44,0.28,0.56,0.56,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Reduction and reconstitution of B-cells in peripheral </text>
   <text y="631.047" x="310.015,315.019,317.521,322.021,326.521,331.525,333.775,338.275,343.279,348.283,350.533,353.035,357.535,365.032,370.036,375.04,379.54,382.042,387.046,389.296,391.798,395.299,398.8,403.804,407.8,411.301,413.551,416.053,421.057,423.307,427.303,431.803,436.807,441.307,448.804,453.304,455.806,460.306,465.31,468.811,471.061,478.558,483.058,488.062,493.066,497.062,501.562,505.063" svgx:width="0.56,0.28,0.5,0.5,0.56,0.25,0.5,0.56,0.56,0.25,0.28,0.5,0.83,0.56,0.56,0.5,0.28,0.56,0.25,0.28,0.39,0.39,0.56,0.44,0.39,0.25,0.28,0.56,0.25,0.44,0.5,0.56,0.5,0.83,0.5,0.28,0.5,0.56,0.39,0.25,0.83,0.5,0.56,0.56,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">blood and lymphoid issues in cynomolgus monkeys </text>
   <text y="642.045" x="310.015,313.012,317.512,320.014,322.516,327.016,333.514,336.016,341.02,345.52,347.77,352.27,357.274,364.771,367.273,372.277,374.779,378.28,381.277,385.273,389.773,392.77,395.272,399.772,404.776,407.026,411.526,414.523,416.773,421.273,425.269,429.265,433.261,435.763,438.265,442.261,447.265,454.762,459.262" svgx:width="0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.56,0.5,0.25,0.5,0.56,0.83,0.28,0.56,0.28,0.39,0.33,0.44,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.44,0.28,0.28,0.44,0.56,0.83,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">following administration of ocrelizumab</text>
   <text y="653.043" x="310.015,315.514,317.764,324.262,328.258,330.76,334.756,338.752,341.254,345.25,349.75,352.252,356.248" svgx:width="0.61,0.25,0.72,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T Gelzeichter</text>
   <text y="650.583" x="359.245" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="653.103" x="362.17,364.42,366.67,373.168,375.418,383.419,387.415,393.913,397.909,401.905,406.405,410.401" svgx:width="0.25,0.25,0.72,0.25,0.89,0.44,0.72,0.44,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K McKeever</text>
   <text y="650.583" x="413.397" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="653.103" x="416.322,418.572,420.822,427.32,429.57,436.068,440.568,445.068,449.064,453.564,458.064,462.564,465.561,472.059,474.561" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.5,0.44,0.5,0.5,0.5,0.33,0.72,0.28,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Auyeung-Kim</text>
   <text y="650.583" x="481.562" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="653.103" x="484.487,486.737,488.987,495.485,497.735,504.233,508.229,511.226,518.228,522.224" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.33,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Herman</text>
   <text y="650.583" x="526.724" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="653.103" x="529.649,531.899" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="664.101" x="310.013,313.514,315.764,321.767,325.763,330.263,334.259" svgx:width="0.39,0.25,0.67,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J Beyer</text>
   <text y="661.583" x="337.258" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="664.103" x="340.183,342.433,344.683,349.687,351.937,357.436,361.432,365.932,370.432,372.934" svgx:width="0.25,0.25,0.56,0.25,0.61,0.44,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Lappin</text>
   <text y="661.583" x="377.434" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="664.103" x="380.359,382.609,384.859,389.863,392.113,395.614,400.114,403.615,407.611,412.111" svgx:width="0.25,0.25,0.56,0.25,0.39,0.5,0.39,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Joseph</text>
   <text y="661.583" x="416.611" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="664.103" x="419.536,421.786,424.036,430.534,432.784,437.788,442.288,446.788" svgx:width="0.25,0.25,0.72,0.25,0.56,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Song</text>
   <text y="661.583" x="451.288" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="664.103" x="454.213,456.463,458.713,465.211,467.461,473.959,478.459,482.959,487.459,491.455" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.5,0.5,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Dybdal</text>
   <text y="661.583" x="493.956" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="672.581" x="310.015" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="675.103" x="312.941,318.44,320.69,322.94,329.438,333.938,336.44,338.942,345.44,349.94,354.44,358.94,361.937,366.941,371.441,373.691,379.19,383.69,387.686,392.186,396.182,398.432,400.682,405.182,409.682,412.184,416.18,418.682,422.678,424.928,430.427,433.928,437.429,441.425,444.926,448.427,454.925,458.921,463.421,465.923,468.173,470.423,474.923,479.423,483.923,486.425,490.925,493.175,497.675,502.175,506.675" svgx:width="0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.72,0.5,0.5,0.5,0.33,0.56,0.5,0.25,0.61,0.5,0.44,0.5,0.44,0.25,0.25,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.61,0.39,0.39,0.44,0.39,0.39,0.72,0.44,0.5,0.28,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">F. Hoffmann-La Roche, Safety Assessment, South San </text>
   <text y="686.101" x="310.016,315.515,319.016,323.516,328.016,332.012,334.514,338.015,342.011,346.511,348.761,351.011,357.014,362.513,364.763,367.013,373.511,378.011,380.513,383.015,387.011,391.511,393.761,398.261,400.763,405.263,407.765,411.761,415.262,417.512" svgx:width="0.61,0.39,0.5,0.5,0.44,0.28,0.39,0.44,0.5,0.25,0.25,0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Francisco, CA, United States, </text>
   <text y="683.583" x="419.761" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="686.103" x="422.686,430.183,434.179,438.679,441.676,448.174,454.672,459.172,463.672,467.668,469.918,472.168,477.172,482.176,488.179,490.429,492.679,498.178,500.68,505.18,507.682,512.182,516.682,519.184,523.18,526.681" svgx:width="0.83,0.44,0.5,0.33,0.72,0.72,0.5,0.5,0.44,0.25,0.25,0.56,0.56,0.67,0.25,0.25,0.61,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MedImmune, LLC, Biologics </text>
   <text y="697.101" x="310.015,314.515,319.015,321.517,325.513,328.015,332.011,334.261,339.76,343.261,346.762,350.758,354.259,357.76,364.258,368.254,372.754,375.256,377.506,379.756,386.254,390.754,393.256,395.758,400.258,404.254,407.755,411.256,415.756,420.256,423.757,428.257,430.507,432.757,440.254,446.752,449.002,451.252,457.75,462.25,464.752,467.254,471.25,475.75,478.0,482.5,485.002,489.502,492.004,496.0,499.501,501.751" svgx:width="0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.61,0.39,0.39,0.44,0.39,0.39,0.72,0.44,0.5,0.28,0.25,0.25,0.72,0.5,0.28,0.28,0.5,0.44,0.39,0.39,0.5,0.5,0.39,0.5,0.25,0.25,0.83,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Safety Assessment, Gaithersburg, MD, United States, </text>
   <text y="694.583" x="504.0" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="697.103" x="506.925,512.424,514.926,517.428,521.424,524.925,529.425,533.925,538.425,540.675" svgx:width="0.61,0.28,0.28,0.44,0.39,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Allergan, </text>
   <text y="708.101" x="310.014,313.011,317.511,321.507,323.757,326.007,328.257,334.755,338.256,342.756,347.256,349.506,354.006,358.506,361.008,365.004,367.506,371.502,373.752,379.251,383.247,387.747,390.249,394.749,399.249,401.751,404.253,408.753,413.253,415.503,417.753,420.75,424.251,428.247,430.749,435.249,439.245,441.495,443.745,449.748,455.247,457.497,459.747,466.245,470.745,473.247,475.749,479.745,484.245,486.495,490.995,493.497,497.997,500.499,504.495,507.996,510.246" svgx:width="0.33,0.5,0.44,0.25,0.25,0.25,0.72,0.39,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.61,0.44,0.5,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.33,0.39,0.44,0.28,0.5,0.44,0.25,0.25,0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Inc., Drug Safety Evaluation, Irvine, CA, United States, </text>
   <text y="705.583" x="512.496" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="708.103" x="515.421,520.92,523.17" svgx:width="0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">F. </text>
   <text y="719.101" x="310.014,316.512,321.012,323.514,326.016,332.514,337.014,341.514,346.014,349.011,354.015,358.515,360.765,366.264,370.764,374.76,379.26,383.256,385.506,387.756,393.255,399.753,402.003,407.502,410.004,414.504,421.002,425.502,429.003,432.999,436.995,440.496,443.997,446.247,448.497,452.997,457.497,461.997,464.499,468.999,471.249,475.749,480.249,484.749,486.999,492.498,495.999,500.499,504.999,508.995,511.497,514.998,518.994,523.494,525.744" svgx:width="0.72,0.5,0.28,0.28,0.72,0.5,0.5,0.5,0.33,0.56,0.5,0.25,0.61,0.5,0.44,0.5,0.44,0.25,0.25,0.61,0.72,0.25,0.61,0.28,0.5,0.72,0.5,0.39,0.44,0.44,0.39,0.39,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.5,0.25,0.61,0.39,0.5,0.5,0.44,0.28,0.39,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hoffmann-La Roche, PD Biomarkers, South San Francisco, </text>
   <text y="730.099" x="310.014,316.017,321.516,323.766,326.016,332.514,337.014,339.516,342.018,346.014,350.514,352.764,357.264,359.766,364.266,366.768,370.764,374.265,376.515" svgx:width="0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">CA, United States, </text>
   <text y="727.583" x="378.766" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="730.103" x="381.691,387.19,389.692,392.194,395.695,399.691,403.192,405.442,407.692,414.19,417.691,422.191,426.691,428.941,433.441,437.941,440.443,444.439,446.941,450.937,453.187,458.686,462.682,466.183,470.179,474.679,478.18,482.176,486.676,488.926,491.176,495.676,500.176,504.676,506.926,513.424,515.926,519.922,524.422,528.922,531.172" svgx:width="0.61,0.28,0.28,0.39,0.44,0.39,0.25,0.25,0.72,0.39,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.5,0.5,0.5,0.25,0.72,0.28,0.44,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Pfizer, Drug Safety Research, San Diego, </text>
  </g>
 </g>
</svg>
